Picture of Laboratory of America Holdings logo

LH Laboratory of America Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Momentum

Relative Strength (%)
1m+3.98%
3m+7.85%
6m-1.86%
1yr+4.19%
Volume Change (%)
10d/3m-32.84%
Price vs... (%)
52w High-12.37%
50d MA+5.89%
200d MA+6.88%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)14.36
PEG Ratio (f)n/a
EPS Growth (f)-10.81%
Dividend Yield (f)1.09%
Valuation (ttm)IndustryMarket
Price to Book Value2.23
Price to Tang. Bookn/a
Price to Free Cashflow15.16
Price to Sales1.48
EV to EBITDA8.95

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital13.95%
Return on Equity17.03%
Operating Margin15.82%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m10,30811,333.411,554.813,978.516,120.914,943.3415,021.7911.03%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+0.99+40.83-6.47+103.26+29.43-21.18-10.81n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Laboratory of America Holdings EPS forecast chart

Profile Summary

Laboratory Corporation of America Holdings is a global life sciences company. The Company provides information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. Its segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). The Dx segment is an independent clinical laboratory business. It offers a menu of frequently requested and specialty diagnostic tests through an integrated network of primary and specialty laboratories across the United States. In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx segment also offers a range of other testing services. The DD segment is a contract research organizations (CRO) business that provides end-to-end drug development services. The DD segment provides these services predominantly to pharmaceutical, biotechnology and medical device companies across the world. It serves clients in more than 100 countries.

Directors

Last Annual
December 31st, 2021
Last Interim
September 30th, 2022
Incorporated
March 8th, 1994
Public Since
April 24th, 1991
No. of Shareholders
1,322
No. of Employees
75,500
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
88,600,000
Blurred out image of a map
Address
358 S MAIN ST, BURLINGTON, 27215-5837
Web
https://www.labcorp.com
Phone
+1 3362291127
Contact
Chas Cook
Auditors
PricewaterhouseCoopers LLP

LH Share Price Performance

Upcoming Events for LH

Q4 2022 Laboratory Corporation of America Holdings Earnings Release

Q4 2022 Laboratory Corporation of America Holdings Earnings Call

Dividend For L1CA34.SA - 0.9252 BRL

Dividend For LH.N - 0.7200 USD

Q1 2023 Laboratory Corporation of America Holdings Earnings Release

Laboratory Corporation of America Holdings Annual Shareholders Meeting

Q2 2023 Laboratory Corporation of America Holdings Earnings Release

Similar to LH

Picture of Agilon Health logo

Agilon Health

us flag iconNew York Stock Exchange

Picture of AMERICAN WELL logo

AMERICAN WELL

us flag iconNew York Stock Exchange

Picture of AMN Healthcare Services logo

AMN Healthcare Services

us flag iconNew York Stock Exchange

Picture of Ardent Health Partners LLC logo

Ardent Health Partners LLC

us flag iconNew York Stock Exchange

Picture of Ati Physical Therapy logo

Ati Physical Therapy

us flag iconNew York Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email